Sudair Pharma Showcases National Pharmaceutical Innovation at the Global Health Exhibition 2025
Sudair Pharma participated in the Global Health Exhibition 2025, showcasing advanced national pharmaceutical capabilities and highlighting the company’s contribution to strengthening Saudi Arabia’s healthcare ecosystem. The SPC booth attracted significant interest and served as a platform for strategic discussions and industry engagement.
Sudair Pharma Welcomes the Minister of Health and Distinguished Delegation at the Global Health Exhibition 2025
Sudair Pharma was honored to welcome His Excellency the Minister of Health, Fahad Al-Jalajel, during its participation in the Global Health Exhibition 2025. The visit highlighted the Kingdom’s commitment to strengthening national pharmaceutical manufacturing and advancing a sustainable healthcare system. Several senior officials and leaders also visited the booth, underscoring Sudair Pharma’s growing impact in shaping the future of Saudi healthcare.
Sudair Pharma Signs Strategic Agreements at GHE25 to Strengthen National Pharmaceutical Supply and Local Manufacturing
Sudair Pharma signed two major agreements during the Global Health Exhibition 2025: a cooperation agreement with NUPCO to enhance the national pharmaceutical supply chain, and a localization agreement with the Local Content & Government Procurement Authority to manufacture Bilotinib locally. These agreements reinforce Sudair Pharma’s commitment to national self-sufficiency and Vision 2030 goals in pharmaceutical manufacturing.